Coherus Oncology (CHRS) Shares Outstanding: History & Chart | TGMCharts
Shares Outstanding: 154,500,959
Coherus Oncology, Inc. (CHRS)
Latest FMP share-count observation
Shares outstanding
154,500,959
Float shares
134,812,908
Source: FMP shares-float. FMP feed updated 2026-10-05 11:13:30 (timezone not supplied). The feed does not specify the effective date of this share count.
Shares outstanding measure the share count in the provider observation. Basic and diluted weighted averages below are EPS calculation inputs. Differences between these counts do not measure new issuance or buybacks.
Weighted Average Basic Shares
CHRS Weighted Average Basic Shares
154.82M
FMP normalized EPS denominators, labeled by statement period end. These are weighted averages, not current shares outstanding. The provider's period duration may include year-to-date values. Q2 FY2026 (2026-06-30): 154.82M.
tgmcharts.com
Weighted Average Diluted Shares
CHRS Weighted Average Diluted Shares
154.82M
FMP normalized EPS denominators, labeled by statement period end. These are weighted averages, not current shares outstanding. The provider's period duration may include year-to-date values. Q2 FY2026 (2026-06-30): 154.82M.
tgmcharts.com
Weighted-average shares by quarterly statement
FMP normalized EPS denominators, labeled by statement period end. These are weighted averages, not current shares outstanding. The provider's period duration may include year-to-date values.
Statement period
Period end
Weighted average basic shares
Weighted average diluted shares
Q2 FY2026
2026-06-30
154,816,912
154,816,912
Q1 FY2026
2026-03-31
136,398,303
136,398,303
Q4 FY2025
2025-12-31
120,369,638
120,369,638
Q3 FY2025
2025-09-30
116,229,170
116,229,170
Q2 FY2025
2025-06-30
116,077,710
116,077,710
Q1 FY2025
2025-03-31
115,857,780
115,857,780
Q4 FY2024
2024-12-31
115,418,069
115,418,069
Q3 FY2024
2024-09-30
115,210,091
115,210,091
Q2 FY2024
2024-06-30
Weighted-average shares by annual statement
FMP normalized EPS denominators, labeled by statement period end. These are weighted averages, not current shares outstanding. The provider's period duration may include year-to-date values.
